Literature DB >> 35238224

Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects.

Yiming Chen1, Xue Wang2, Yijie Chen3, WenWen Ning3, Lei Chen4, Yixuan Yin1, Wen Zhang1, Jiejing Lian1, Hao Wang1.   

Abstract

The correlation of maternal serum alpha-fetoprotein (AFP) variants (AFP-L2, AFP-L3), free beta-human chorionic gonadotropin (free β-hCG), and open neural tube defects (ONTDs) during the second trimester, and the screening efficiency of different risk models remain indistinct. We conducted a retrospective case-control study, and studied 57 pregnant women with ONTD fetuses and 569 pregnant women with normal fetuses. The receiver operating characteristic curve method indicated the best cutoff value and area under the curve (AUC). The predictive value of ONTD risk models by free β-hCG, AFP, AFP-L2, and AFP-L3 was investigated via integrated discrimination improvement (IDI), net reclassification improvement (NRI), and decision curve analysis (DCA). Compared to the control group, AFP, AFP-L2, and AFP-L3 levels were significantly higher, while free β-hCG level was significantly lower in the study group. The triple-index model of free β-hCG + AFP-L2 + AFP-L3 and the dual-index model of AFP-L2 + AFP-L3 showed the best predictive values, respectively (AUC = 0.905; AUC = 0.885). The order of the single-index model AUCs was AFP-L3 > AFP-L2 > AFP > free β-hCG. The negative predictive value, false positive rate, and negative likelihood ratio of AFP-L2, AFP-L3 alone, or combined with free β- hCG were better than those of AFP alone; however, the positive likelihood ratio was the opposite. The replacement of AFP by AFP-L2 or AFP-L3 combined with free β-hCG increased the IDI and NRI for predicting ONTD. The top five DCAs were AFP-L2 + free β-hCG, free β-hCG, AFP-L3, AFP + free β-hCG, and AFP. Indicators of maternal serum free β-hCG, AFP-L2, and AFP-L3 in the second trimester exhibited high sensitivity and specificity screening for ONTD fetuses. Risk models constructed using AFP-L2 + AFP-L3 and AFP-L2 + AFP-L3 + free β-hCG demonstrated better screening efficiency.

Entities:  

Keywords:  L3; Second trimester; alpha-fetoprotein variants L2; free beta-human chorionic gonadotropin; open neural tube defects; prenatal screening; risk model

Mesh:

Substances:

Year:  2022        PMID: 35238224      PMCID: PMC9160932          DOI: 10.1177/15353702221080458

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  23 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

2.  Integrated discrimination improvement and probability-sensitive AUC variants.

Authors:  Ben Van Calster; Sabine Van Huffel
Journal:  Stat Med       Date:  2010-01-30       Impact factor: 2.373

3.  Indigenization of the median of markers for Down syndrome screening based on statistical analysis of medical big data.

Authors:  Zhu-Ming Hu; Li-Li Luo; Ling Li; Si-Da Dai; Hong-Guo Zhang; Rui-Zhi Liu
Journal:  Taiwan J Obstet Gynecol       Date:  2020-07       Impact factor: 1.705

Review 4.  Overview on neural tube defects: From development to physical characteristics.

Authors:  Laura Avagliano; Valentina Massa; Timothy M George; Sarah Qureshy; Gaetano Pietro Bulfamante; Richard H Finnell
Journal:  Birth Defects Res       Date:  2018-11-12       Impact factor: 2.344

5.  A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy.

Authors:  Yiming Chen; Zhen Xie; Xue Wang; Qingxin Xiao; Xiao Lu; Sha Lu; Yezhen Shi; Shaolei Lv
Journal:  EPMA J       Date:  2020-06-19       Impact factor: 6.543

6.  Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

7.  Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Glenn E Palomaki; Caleb Bupp; Anthony R Gregg; Mary E Norton; Devin Oglesbee; Robert G Best
Journal:  Genet Med       Date:  2019-11-08       Impact factor: 8.822

8.  DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study.

Authors:  Prashant Kotwani; Wesley Chan; Francis Yao; Neil Mehta
Journal:  Clin Gastroenterol Hepatol       Date:  2021-01-29       Impact factor: 11.382

9.  New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age.

Authors:  Yiming Chen; Xue Wang; Liyao Li; Sha Lu; Zhifen Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2020-12-14       Impact factor: 3.007

10.  Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.

Authors:  Xueying Wang; Yangyu Zhang; Na Yang; Hua He; Xuerong Tao; Changgui Kou; Jing Jiang
Journal:  Biomed Res Int       Date:  2020-09-17       Impact factor: 3.411

View more
  1 in total

1.  Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.

Authors:  Yiming Chen; Yijie Chen; Wenwen Ning; Wen Zhang; Liyao Li; Xiaoying Wang; Yixuan Yin; Huimin Zhang
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.